MedTrace Logo

An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

NCT00297323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2010-04-27

No results posted yet for this study

Summary

The purpose of this observational study is to evaluate the safety of topiramate in adults and children with epilepsy (or seizures) who have not received or have not responded to treatment with previous antiepileptic medication.

Conditions

  • Seizures, Epileptic

Interventions

DRUG

Topiramate

75 patients over the age of 2 years old with epilepsy.

Sponsors & Collaborators

  • Janssen Cilag Pharmaceutica S.A.C.I., Greece

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag Pharmaceutica S.A.C.I. Clinical Trial · Janssen-Cilag Pharmaceutica S.A.C.I.

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2007-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00297323 on ClinicalTrials.gov